News AI predicts heart attack risk factors from retinal scans Artificial Intelligence can be used to predict heart attack risk using retinal images, according to new research backed by Google.
Views & Analysis Digital health round-up: Could Nokia kill off digital health... Richard Staines gives a round-up of the latest developments in digital health over the last week.
News FDA makes history, approving Spark's eye gene therapy Christmas has come a few days early for Spark Therapeutics after the FDA approved its ground-breaking gene therapy for a rare eye disease.
Partner Content Partner Content Europe’s Leading Ophthalmic Conference is Just 1 week away Ophthalmic Drugs
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
